[ad_1]
Cheaper than Pfizer Modena and can be made in Korea
AFP 연합 뉴스 “style =” padding: 0px; margin: 0px “>
▲ Corona 19 vaccine is being developed by AstraZeneca, UK.
AFP Yonhap News
The government has signed a vaccine contract with AstraZeneca, a developer of vaccines for a new coronavirus infection (Corona 19).
A health official said on day 3: “We recently signed a vaccine supply contract with AstraZeneca and we plan to announce the current status of the contract and the amount to be secured next week when negotiations with individual vaccine developers conclude soon.”
The AstraZeneca vaccine requires two doses and, as a result of the initial data analysis of the phase 3 clinical trial, the prophylactic effect of the vaccine was 70-90% depending on the method of administration. The company previously promised a supply price of $ 3 to $ 5 (about 3,000 to 5,500 won) per dose (for one dose).
The government has negotiated purchase contracts for 5 corona vaccine products19 that entered phase 3 clinical trials. AstraZeneca, known to have signed a contract for the first time, is reported to have been negotiating with Pfizer, Johnson & Johnson, Modena and NovaVax, who approved emergency use in the UK on Day 2.
Pfizer and Moderna have stated that the vaccines they are developing have preventive effects of 95% and 94.1%, respectively. The price is $ 19.5 per dose for Pfizer (about 21,500 won) and $ 15-25 for Modena (about 16,500-27,000 won). Two doses of the Pfizer and Modena vaccine are also required.
The AstraZeneca vaccine has the advantage that it can be distributed at 2 to 8 degrees compared to Pfizer, which must be distributed through a ‘cold chain’ at cryogenic temperatures below -70 ° C. Furthermore, it has the advantage that domestic manufacturing is possible by signing a vaccine shipment production contract with SK Bioscience in July.
Health and Welfare Minister Park Neung-hoo recently said: “We are looking for considerably more contracts than 30 million people, which is 60% of the total population.” In next year’s budget, 900 billion won has been allocated to purchase vaccines to increase the number of vaccination targets to 44 million.
Reporter Kim Yoomin [email protected]
